136 related articles for article (PubMed ID: 8579005)
1. [Blocking antibodies in Dermatophagoides allergy].
Sánchez Armengol A; Castillo Gómez J; Ortega Ruiz F; Segado Soriano A
Allergol Immunopathol (Madr); 1995; 23(6):271-6. PubMed ID: 8579005
[TBL] [Abstract][Full Text] [Related]
2. [Comparative studies of the effectiveness of specific immunotherapy in house dust mite allergy].
Ebner H; Neuchrist C; Havelec L; Kraft D
Wien Klin Wochenschr; 1989 Aug; 101(15):504-11. PubMed ID: 2672610
[TBL] [Abstract][Full Text] [Related]
3. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
[TBL] [Abstract][Full Text] [Related]
4. Comparison of conventional and rush immunotherapy with der PI in childhood respiratory allergy.
Akmanlar N; Altintaş DU; Güneşer KS; Yilmaz M; Bingöl G
Allergol Immunopathol (Madr); 2000; 28(4):213-8. PubMed ID: 11022267
[TBL] [Abstract][Full Text] [Related]
5. [Apropos of sublingual specific immunotherapy].
Sabbah A
Allerg Immunol (Paris); 1998 Apr; 30(4):97-8. PubMed ID: 9631689
[No Abstract] [Full Text] [Related]
6. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
7. Immunologic evaluation of 24 month course of sublingual immunotherapy.
Tari MG; Mancino M; Madonna F; Buzzoni L; Parmiani S
Allergol Immunopathol (Madr); 1994; 22(5):209-16. PubMed ID: 7840022
[TBL] [Abstract][Full Text] [Related]
8. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
9. A case control study of dermatophagoides immunotherapy in children below 5 years of age.
Di Bernardino C; Di Bernardino F; Colombo R; Angrisano A
Allerg Immunol (Paris); 2002 Feb; 34(2):56-9. PubMed ID: 11933755
[TBL] [Abstract][Full Text] [Related]
10. [Effect of immunotherapy on house dust mite allergen-specific IgG1 and igG4 antibodies in nasal secretion for patients with perennial allergic rhinitis].
Xiao SF; Wang QH
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Dec; 39(12):725-9. PubMed ID: 15813014
[TBL] [Abstract][Full Text] [Related]
11. [Topical nasal immunotherapy with Dermatophagoides pteronyssinus extract].
Muñoz-López F; Martín Mateos A; Moreira A; Martínez Marín F
Allergol Immunopathol (Madr); 1994; 22(3):132-4. PubMed ID: 7976962
[No Abstract] [Full Text] [Related]
12. A comparative study of the clinical efficacy of immunotherapy and conventional pharmacological treatment for patients with perennial allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Yamada K; Sakamoto H; Nasako Y; Hayashi M; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():102-12. PubMed ID: 9879409
[TBL] [Abstract][Full Text] [Related]
13. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus.
Tsai JJ; Liao EC; Tsai FH; Hsieh CC; Lee MF
J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124
[TBL] [Abstract][Full Text] [Related]
14. Parameters of immunotherapy: a retrospective study.
Malet A; Lluch M; Valero A; Amat P
Allergol Immunopathol (Madr); 1993; 21(1):7-10. PubMed ID: 8328357
[TBL] [Abstract][Full Text] [Related]
15. Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus.
Piazza I; Bizzaro N
Ann Allergy; 1993 Nov; 71(5):461-9. PubMed ID: 7755664
[TBL] [Abstract][Full Text] [Related]
16. [Respiratory allergy to house dust: Dermatophagoides pteronyssinus versus Dermatophagoides farinae] ].
Popović-Grle S
Lijec Vjesn; 2001; 123(9-10):233-7. PubMed ID: 11845577
[TBL] [Abstract][Full Text] [Related]
17. Mite allergy is associated with a specific profile of IgG epitopes recognized on antigen p1 of Dermatophagoides pteronyssinus.
Duchateau J; Michils A; Michel O; Baras L
Clin Exp Allergy; 1997 Mar; 27(3):296-305. PubMed ID: 9088656
[TBL] [Abstract][Full Text] [Related]
18. [Effect of specific desensitization therapy in combination with an immunopotentiator, Neurotropin, on perennial nasal allergy--with special reference to mite specific IgG and IgG4 antibody levels].
Ukai K; Sakakura Y; Baba S; Usami A; Takimoto I; Nishimura T
Arerugi; 1990 Oct; 39(10):1437-47. PubMed ID: 2260931
[TBL] [Abstract][Full Text] [Related]
19. Immunologic and clinical evaluation of a 12-month course of specific immunotherapy.
Scordamaglia A; Pizzorno G; Caria M; Passalacqua G; Ruffoni S; Ciprandi G; Canonica GW
Ann Allergy; 1989 Jul; 63(1):31-6. PubMed ID: 2742215
[TBL] [Abstract][Full Text] [Related]
20. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
Ameal A; Vega-Chicote JM; Fernández S; Miranda A; Carmona MJ; Rondón MC; Reina E; García-González JJ
Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
